The research reviewed above reveals that ITGA9 has the potential to become a diagnostic biomarker for hepatocellular carcinoma, provides a potential treatment solution and, more importantly, shows notable tumour heterogeneity in different cancer types. This evidence concerns the gene ITGA9 and hepatocellular carcinoma.